JACK vs REGN · rev $1.47B vs P/E 14, rev $14.34B
Jacktel AS (JACK) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Jacktel AS (JACK) is a restaurants company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported JACK revenue for 2025-09-28 was $1.47B. Net income was -$80.7M. Revenue was down 6.7% from 2024-09-29 to 2025-09-28. JACK currently screens at market cap $215.9M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
JACK currently screens at market cap $215.9M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the JACK and REGN stock pages for the full models.
Not investment advice.